2024 annual financial data
Corbus Pharmaceuticals Holdings 2024 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -48,721,000 USD and net income was -40,209,000 USD.
Operating cash flow was -41,794,000 USD.
Get free Corbus Pharmaceuticals Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -48,721,000 USD
- Net income
- -40,209,000 USD
- Operating cash flow
- -41,794,000 USD